It induces a significant weight loss and an improvement in lipid parameters, blood pressure, glycaemic indices and insulin sensitivity in patients with obesity and type 2 diabetes mellitus. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.